Financials
- Market Capitalization 41.5705 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.16
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 5467 | CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1297 USD | +9.08% | +12.88% | +20.09% | +314.38% | 0 USD | ||
| 6285 | ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -68.75% | 0 USD | ||
| 6643 | NAMSW NewAmsterdam Pharma Company N.V. - Warrant | 12.6500 USD | 0.00% | 0.00% | +1.20% | -51.53% | 2.54 B USD | ||
| 6710 | DRTSW Alpha Tau Medical Ltd. - Warrant | 3.7350 USD | -4.72% | -2.73% | -0.13% | +1145.00% | 1.26 B USD |